about
Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: the essential NCD health intervention project.The Do-Well study: protocol for a randomised controlled trial, economic and qualitative process evaluations of domiciliary welfare rights advice for socio-economically disadvantaged older people recruited via primary health care.Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care.Fragility fracture: recent developments in risk assessment.25-hydroxyvitamin D and increased all-cause mortality in very old women: the Newcastle 85+ study.The bone mineral content of weight-bearing bones is influenced by the ratio of sitting to standing height in elderly Gambian women.Back pain in osteoporotic vertebral fractures.Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D₃.The role of vitamin D in maintaining bone health in older people.Treatment of osteoporosis in women intolerant of oral bisphosphonates.Vitamin D and bone health outcomes in older age.Assessing the need for arthritis training among paid carers in UK residential care homes: A focus group and interview study.The effects of parathyroid hormone peptides on the peripheral skeleton of postmenopausal women. A systematic review.Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon.Changes in blood pressure and lipids associated with rural to urban migration in Tanzania.The use of verbal autopsy in attributing cause of death from epilepsy.The pitfalls of measuring changes in smoking habits. Essential NCD Health Intervention Project Team.Diabetes, falls and fractures.Overseas electives.Implications of guidelines for osteoporosis and its treatment.National Osteoporosis Society vitamin D guideline summary.The Role of Vitamin D in Disease Progression in Early Parkinson's Disease.Diabetes in care homes: current care standards and residents' experience.Comparison of ultrasound measurements at the heel between adults with mental retardation and control subjects.Can orthogeriatics do more than save lives?Low bone mineral density measurements in care home residents--a treatable cause of fractures.Purity, pragmatism and hip protector padsRetrospective analysis of the role of serum vitamin D in early rheumatic diseaseRandomized controlled trial of vitamin D supplementation in older people to optimize bone healthDoes domiciliary welfare rights advice improve health-related quality of life in independent-living, socio-economically disadvantaged people aged ≥60 years? Randomised controlled trial, economic and process evaluations in the North East of England.Physical activity and its relationship with obesity, hypertension and diabetes in urban and rural CameroonNo effect of monthly supplementation with 12000 IU, 24000 IU or 48000 IU vitamin D3 for one year on muscle function: The vitamin D in older people study.Consequences of withholding testosterone treatmentBiochemical indices and neuromuscular function tests in rural Gambian schoolchildren given a riboflavin, or multivitamin plus iron, supplementClinical guidelines for older adults with diabetes mellitusThe impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databasesVitamin D deficiency--can old age learn from childhood?Here comes the sun: good news for bone health!Fracture prevention in care home residents: is vitamin D supplementation enough?Vitamin D and fractures: where are we now?
P50
Q30327034-E1DB144C-B8BF-4ACF-AAD9-E12CFE624DEDQ31063117-71A84BEA-924C-45F8-9A4A-C6F537027F9EQ33939025-6A5EAD65-6C44-4786-9D2A-9CD9ADDFAB13Q35039567-61E2EDA6-9ABB-4EF0-8A73-EDBADDAFB1CFQ35522784-920BE8DE-1BD2-4FF5-8960-89C9D83338E1Q36788812-506D47BF-E56D-4B7B-9B9D-C13FBF329801Q37028806-C4884703-E688-4C85-B490-37716A8A6AD8Q37359637-4A18EFBD-4F41-4091-A6BD-E5B376AAC9C0Q37722775-E2307563-CA65-4A3A-9560-D841E7F3B8AEQ37955527-1D4221F5-394D-431B-8E1E-641CAE7F9C34Q38135885-13247C95-D35F-44B7-B1E5-A2D687F55772Q38626438-D28FCE0F-6AC3-4B3D-A13F-DBF5A0456D68Q38912223-FFA175D8-A39E-4EB9-9077-B54FC91FDD66Q39686007-50C2B6B5-C92B-4A78-9DA9-7C395DF54AA0Q39757127-AD6DA8FB-1472-4017-A0A0-9C2E288B3A70Q42677223-5EC117EC-E8C6-4965-B4C1-3296C136C7FBQ43951636-8C919237-09F6-4C07-8A22-45FF5EEE9DBBQ46165508-DD5B0CCC-FA01-40FA-939E-47DDF269E092Q46419088-6E6BDB10-466F-42D9-ACC7-9DF412857994Q47177624-46683385-096D-4A26-8852-E1087B496EFCQ48842263-D3FFD8DE-393B-45FA-AE0C-5317038AFF3AQ49300156-238FF348-4F0F-4C7B-A9E3-417FCA035FB8Q50792966-AF8C7465-844C-4CB0-B11B-1DD3ED2C267AQ50882464-36A4C48D-6DCA-4BE4-8394-0BE01BAFF598Q51829225-C92575D3-B7F9-4A7C-8099-A146C9170D79Q51923107-1CED04AF-6141-469C-9C9E-CA9F7230E7DCQ56888405-5A93601F-F058-4CFC-BEE9-58ECD3394261Q60061981-731D8DE4-B659-4996-A8F9-D28D40C57066Q60781842-6518AD18-2C1B-415A-9A94-C0AD53B58E5EQ61192768-B3515319-A45F-44C1-9621-285A57F5CD8FQ61910401-3A096C92-B2BA-4C2C-BAD0-6272EDE74BCAQ64971693-B86DBDBF-75F9-4A23-85C0-E9A2C9FB43F2Q71447262-B4CE6F10-6A3A-444E-800B-9676C43A27C8Q72872840-FBF9912D-76CA-4411-887E-BEF10B773426Q79260474-2780B65E-FEAB-4A42-8B35-81D9223F6F39Q79883788-94E4B328-9B25-4369-B675-910E48590A19Q80492277-E091C080-6C29-4FE6-8643-73ED4BFEEBE5Q83022150-60C8629F-A5E7-4827-9739-E828002B1E68Q83954489-93061F39-8AEF-4E4D-861A-8F1404DD4E76Q84026160-BFD3C2E8-BC80-4521-8CFB-3525A888AD15
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Terry J Aspray
@nl
Terry J Aspray
@sl
Terry J. Aspray
@en
Terry J. Aspray
@es
type
label
Terry J Aspray
@nl
Terry J Aspray
@sl
Terry J. Aspray
@en
Terry J. Aspray
@es
prefLabel
Terry J Aspray
@nl
Terry J Aspray
@sl
Terry J. Aspray
@en
Terry J. Aspray
@es
P106
P1153
6603706653
P31
P496
0000-0001-9522-6069